Back to MW MARSHALL WACE, LLP

PDSBPDSB
20 quarters

Position history for MWMARSHALL WACE, LLP's holdings in PDS BIOTECHNOLOGY CORP

Yes. Marshall Wace holds 147,171 shares of PDSB (PDS Biotechnology), worth $129,510, as of its Q2 2026 13F filing. It opened the position in Q2 2026.

Current Value

$129,510

Current Shares

147,171

Total Value Change

-$71,490

Total Shares Change

+102,939

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
New
147,171
-
$129,5100.0%$0.88
31
2025-Q3
Exited
0
-100.0%
$00.0%$1.01
0
2025-Q2
New
68,454
-
$91,0440.0%$1.33
30
2025-Q1
Exited
0
-100.0%
$00.0%$1.19
0
2024-Q4
Increased
39,024
+38.5%
$63,6090.0%$1.63
28
2024-Q3
New
28,187
-
$107,6740.0%$3.82
30
2024-Q2
Exited
0
-100.0%
$00.0%$2.93
0
2024-Q1
New
41,221
-
$163,2350.0%$3.96
31
2023-Q4
Exited
0
-100.0%
$00.0%$4.97
0
2023-Q3
Decreased
68,795
-6.0%
$347,4160.0%$5.05
0
2023-Q2
Decreased
73,220
-47.3%
$368,2970.0%$5.03
0
2023-Q1
Increased
139,008
+290.1%
$854,8990.0%$6.15
40
2022-Q4
Increased
35,632
+29.1%
$470,3420.0%$13.20
30
2022-Q3
Decreased
27,598
-64.0%
$82,0000.0%$2.97
0
2022-Q2
Decreased
76,745
-55.0%
$281,0000.0%$3.65
0
2022-Q1
Increased
170,479
+147.3%
$1.1M0.0%$6.19
41
2021-Q4
Increased
68,929
+18.5%
$557,0000.0%$8.10
29
2021-Q3
New
58,173
-
$867,0000.0%$14.90
34
2021-Q2
Exited
0
-100.0%
$00.0%$12.55
0
2021-Q1
New
44,232
-
$201,0000.0%$4.55
32

Other major holders of PDSB: BlackRock Finance, Inc., TWO SIGMA ADVISERS, LP, TWO SIGMA INVESTMENTS, LP

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used